233 related articles for article (PubMed ID: 33603270)
1. Rheumatoid Arthritis Interstitial Lung Disease: Measuring and Predictive Factors Among Patients Treated in Rehabilitation Clinics at Royal Medical Services.
Alsharari DM; Obeidat LA; Khasawneh HK; Alhmar MRH; Khasawneh RM; Bataineh ZS; Aldhoun AA
Med Arch; 2020 Dec; 74(6):450-454. PubMed ID: 33603270
[TBL] [Abstract][Full Text] [Related]
2. Assessment of interstitial lung disease among black rheumatoid arthritis patients.
McFarlane IM; Zhaz SY; Bhamra MS; Burza A; Kolla S; Alvarez MR; Koci K; Taklalsingh N; Pathiparampil J; Freeman L; Kaplan I; Kabani N; Ozeri DJ; Watler E; Frefer M; Vaitkus V; Matthew K; Arroyo-Mercado F; Lyo H; Zrodlowski T; Feoktistov A; Sanchez R; Sorrento C; Soliman F; Valdez FR; Dronamraju V; Trevisonno M; Grant C; Clerger G; Amin K; Dawkins M; Green J; Moon J; Fahmy S; Waite SA
Clin Rheumatol; 2019 Dec; 38(12):3413-3424. PubMed ID: 31471819
[TBL] [Abstract][Full Text] [Related]
3. Patterns of interstitial lung disease and mortality in rheumatoid arthritis.
Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
Rheumatology (Oxford); 2017 Mar; 56(3):344-350. PubMed ID: 27940586
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.
Li L; Liu R; Zhang Y; Zhou J; Li Y; Xu Y; Gao S; Zheng Y
Clin Rheumatol; 2020 May; 39(5):1457-1470. PubMed ID: 31858341
[TBL] [Abstract][Full Text] [Related]
5. Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease.
Castellanos-Moreira R; Rodríguez-García SC; Gomara MJ; Ruiz-Esquide V; Cuervo A; Casafont-Solé I; Ramírez J; Holgado S; Gómez-Puerta JA; Cañete JD; Haro I; Sanmarti R
Ann Rheum Dis; 2020 May; 79(5):587-594. PubMed ID: 32156708
[TBL] [Abstract][Full Text] [Related]
6. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts.
Kiely P; Busby AD; Nikiphorou E; Sullivan K; Walsh DA; Creamer P; Dixey J; Young A
BMJ Open; 2019 May; 9(5):e028466. PubMed ID: 31061059
[TBL] [Abstract][Full Text] [Related]
7. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities.
Salaffi F; Carotti M; Di Carlo M; Tardella M; Giovagnoni A
Medicine (Baltimore); 2019 Sep; 98(38):e17088. PubMed ID: 31567944
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
Kelly CA; Saravanan V; Nisar M; Arthanari S; Woodhead FA; Price-Forbes AN; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A;
Rheumatology (Oxford); 2014 Sep; 53(9):1676-82. PubMed ID: 24758887
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
Wang HF; Wang YY; Li ZY; He PJ; Liu S; Li QS
Ann Med; 2024 Dec; 56(1):2332406. PubMed ID: 38547537
[TBL] [Abstract][Full Text] [Related]
10. Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease.
Zhang Y; Li H; Wu N; Dong X; Zheng Y
Clin Rheumatol; 2017 Apr; 36(4):817-823. PubMed ID: 28191607
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with interstitial lung disease in patients with rheumatoid arthritis: A systematic review and meta-analysis.
Zhang M; Yin J; Zhang X
PLoS One; 2023; 18(6):e0286191. PubMed ID: 37352174
[TBL] [Abstract][Full Text] [Related]
12. Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis.
Kurata I; Tsuboi H; Terasaki M; Shimizu M; Toko H; Honda F; Ohyama A; Yagishita M; Osada A; Ebe H; Kawaguchi H; Takahashi H; Hagiwara S; Asashima H; Kondo Y; Matsumoto I; Sumida T
Intern Med; 2019 Jun; 58(12):1703-1712. PubMed ID: 30799358
[TBL] [Abstract][Full Text] [Related]
13. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.
Hyldgaard C; Hilberg O; Pedersen AB; Ulrichsen SP; Løkke A; Bendstrup E; Ellingsen T
Ann Rheum Dis; 2017 Oct; 76(10):1700-1706. PubMed ID: 28611082
[TBL] [Abstract][Full Text] [Related]
14. Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA.
Shidara K; Hoshi D; Inoue E; Yamada T; Nakajima A; Taniguchi A; Hara M; Momohara S; Kamatani N; Yamanaka H
Mod Rheumatol; 2010 Jun; 20(3):280-6. PubMed ID: 20217173
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.
Chartrand S; Lee JS; Swigris JJ; Stanchev L; Fischer A
Lung; 2019 Dec; 197(6):709-713. PubMed ID: 31583453
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.
Bernstein EJ; Barr RG; Austin JHM; Kawut SM; Raghu G; Sell JL; Hoffman EA; Newell JD; Watts JR; Nath PH; Sonavane SK; Bathon JM; Majka DS; Lederer DJ
Thorax; 2016 Dec; 71(12):1082-1090. PubMed ID: 27609750
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis.
Restrepo JF; del Rincón I; Battafarano DF; Haas RW; Doria M; Escalante A
Clin Rheumatol; 2015 Sep; 34(9):1529-36. PubMed ID: 26255186
[TBL] [Abstract][Full Text] [Related]
18. Expression and diagnostic value of interleukin-22 in rheumatoid arthritis-associated interstitial lung disease.
Fang Q; Xie J; Zong J; Zhou Y; Zhou Q; Yin S; Cao L; Yin H; Zhou D
Int Immunopharmacol; 2024 Jun; 134():112173. PubMed ID: 38728884
[TBL] [Abstract][Full Text] [Related]
19. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Solomon JJ; Danoff SK; Goldberg HJ; Woodhead F; Kolb M; Chambers DC; DiFranco D; Spino C; Haynes-Harp S; Hurwitz S; Peters EB; Dellaripa PF; Rosas IO;
Adv Ther; 2019 Nov; 36(11):3279-3287. PubMed ID: 31515704
[TBL] [Abstract][Full Text] [Related]
20. Distinctive Clinical Characteristics and Outcome of ILD-Onset Rheumatoid Arthritis and ACPA-Positive ILD: a Longitudinal Cohort of 282 Cases.
Chen RX; Zhao LD; Xiao XY; Song L; Du HY; Xu ZJ; Feng RE; Yang HX; Fei YY; Zhang W; Zhang FC; Chen H; Zhang X
Clin Rev Allergy Immunol; 2021 Feb; 60(1):46-54. PubMed ID: 33170478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
